What's new

Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord, vildagliptin / metformin hydrochloride, Date of authorisation: 24/03/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord, vildagliptin / metformin hydrochloride, Date of authorisation: 24/03/2022, Revision: 3, Status: Authorised

Apr 4, 2025 - 11:02
 0
Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord, vildagliptin / metformin hydrochloride, Date of authorisation: 24/03/2022, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord, vildagliptin / metformin hydrochloride, Date of authorisation: 24/03/2022, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept...

Next Article

Publix faces legal action alleging overcharging at self-checkout

Related Posts

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

European Shortages Monitoring Platform (ESMP) open Appl...

Mar 27, 2025  0

EMEA-002713-PIP02-21-M01

EMEA-002713-PIP02-21-M01

Feb 17, 2025  0